News Focus
News Focus
Followers 170
Posts 23221
Boards Moderated 1
Alias Born 12/09/2004

Re: BIOChecker4 post# 518859

Wednesday, 05/27/2026 11:50:01 PM

Wednesday, May 27, 2026 11:50:01 PM

Post# of 518980
You have your opinion and I appreciate it.
I disagree with it.

First we don't know for sure that those people left the company. If they did that expertise can be replaced or contracted for, so that isn't really an issue.
You don't know what state the plans for further trials is in.
Fragile X trial shouldn't require a long time to run and should be relatively easy to recruit as one possible trial.

It appears to me that you are assuming the worst case with your analysis. That is always worth doing. It also is not the likely path forward.

The path forward is unclear since we don't know what the situation is with Missling and what consequence that may have for the company.
Until that is clarified making predictions on what is the best path forward is risky.

Success is the best revenge.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News